GB Patent

GB982072A — Benzothiadiazine-1,1-dioxides and processes for their manufacture

Assigned to MSD International Holdings GmbH · Expires 1965-02-03 · 61y expired

What this patent protects

The invention comprises compounds of the formula <FORM:0982072/C2/1> and the tautomers and alkali-metal salts thereof wherein X represents halogen or trifluoromethyl in the 6- or 7-position, Y represents hydrogen or a halogen, methyl or trifluoromethyl substituent in the 6-…

USPTO Abstract

The invention comprises compounds of the formula <FORM:0982072/C2/1> and the tautomers and alkali-metal salts thereof wherein X represents halogen or trifluoromethyl in the 6- or 7-position, Y represents hydrogen or a halogen, methyl or trifluoromethyl substituent in the 6-, 7- or 8-position and R is a saturated aliphatic hydrocarbon group of not more than 6 carbon atoms, e.g. alkyl or cycloalkyl such as cyclopropyl; and their preparation by (a) heating a compound of the formula <FORM:0982072/C2/2> wherein Z is H, benzyl or a lower aliphatic hydrocarbon group, Q may be (H,H), (H, RCO-), (RCO-, RCO-) or RC(O.lower alkyl) = and T is H or R.CO-, provided that when Z is methyl or ethyl Q is not RC(O.lower alkyl) = and that when Q and T is hydrogen, the heating is effected in the presence of a lower saturated aliphatic monocarboxylic acid R.COOH, or an ester, anhydride, acid halide or ortho ester thereof, or an a -lower alkoxy-aldehyde diacetal; (b) heating an X,Y-substituted-2-sulphamyl aniline with an ortho ester of the formula R.C(O.lower alkyl)3 or an acid RCOOH or ester, anhydride or halide thereof; (c) dehydrogenating the corresponding 3,4 - dihydro - benzothiadiazine analogue by treatment with a mild oxidizing agent such as potassium permanganate; or (d) removing hydrogen halide from a corresponding 3,4-dihydro-benzothiadiazine analogue bearing an a -haloalkyl group in place of the alkyl group R. Sulphamylanilines of the formula II are made by treating an X,Y-substituted-o-chloronitrobenzene with thiourea and benzyl chloride to give the corresponding o-benzylthio-nitrobenzene, oxidizing with chlorine to the o-nitrobenzenesulphonyl chloride, reacting with ammonia to give the sulphonamide, reducing to the o-aminobenzenesulphonamide and acylating to introduce groups RCO- on the amino and/or sulphonamido nitrogen atom, or acylating the nitrobenzenesulphonamide followed by reduction to give products acylated on the sulphonamide group only. Alternatively an X,Y-substituted o-amino-benzenesulphonamide bearing a lower aliphatic hydrocarbon or a benzyl substituent on the sulphonamide nitrogen atom may be treated an ortho ester R(COC2H5)3 to form a corresponding sulphonamide bearing an a -alkoxyalkylidene-amino substituent, e.g. R.C(OC2H5) =, in the o-position. o - Diacylamino - benzenesulphonic acids bearing substituents X and Y, in which the acyl groups are of the formula RCO-, are prepared by reacting the appropriate 2-amino-benzenesulphonic acid (e.g. 2-amino-5-chloro-benzenesulphonic acid) with an acylating agent of the formula RCOCl, (RCO)2O or R COONa (e.g. acetic anhydride). Pharmaceutical preparations having blood pressure lowering activity comprise the above compounds of the invention and a carrier suitable for enteral or parenteral administration, for example in the form of tablets, capsules, suppositories, elixirs, emulsions or injectable preparations.

Drugs covered by this patent

Patent Metadata

Patent number
GB982072A
Jurisdiction
GB
Classification
Expires
1965-02-03
Drug substance claim
No
Drug product claim
No
Assignee
MSD International Holdings GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.